BamSEC and AlphaSense Join Forces
Learn More

CNS Pharmaceuticals Inc. – Underwriting Agreements

NASDAQ: CNSP    
Share price (7/2/26): $5.07    
Market cap (7/2/26): $7.410 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 7 pages Placement Agency Agreement Dated May 4, 2026
12/34/56
EX-1.1
from 8-K 7 pages Exhibit 1.1
12/34/56
EX-1.1
from S-1 7 pages Exhibit 1.1
12/34/56
EX-1.1
from DRS 7 pages Exhibit 1.1
12/34/56
EX-1.1
from 8-K 6 pages Exhibit 1.1
12/34/56
EX-1.1
from 8-K 33 pages Cns Pharmaceuticals, Inc. Common Stock Sales Agreement
12/34/56
EX-1.1
from S-1 7 pages Exhibit 1.1
12/34/56
EX-1.1
from 8-K 7 pages Exhibit 1.1
12/34/56
EX-1.1
from S-1 7 pages Exhibit 1.1
12/34/56
EX-1.1
from 8-K 33 pages Cns Pharmaceuticals, Inc. Common Stock ($0.001 Par Value Per Share) Capital on Demand™ Sales Agreement
12/34/56
EX-1.1
from 8-K 33 pages Underwriting Agreement Between Cns Pharmaceuticals, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Cns Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 37 pages Underwriting Agreement Between Cns Pharmaceuticals, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters 1 Cns Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1 33 pages Underwriting Agreement Between Cns Pharmaceuticals, Inc. and A.G.P./ALLIANCE Global Partners, as Representative of the Several Underwriters Cns Pharmaceuticals, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 38 pages Underwriting Agreement Between Cns Pharmaceuticals, Inc. and Benchmark Company, LLC as Representative of the Several Underwriters 1 Cns Pharmaceuticals, Inc. Underwriting Agreement
12/34/56